philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
DP
Person · officer / director

Dr Peter Jones

Chief Scientific Officer & Res. Dir. · Van Andel Research Institute

Chief Scientific Officer & Res. Dir. at Van Andel Research Institute. Listed as an officer, director, or key employee across 2 organizations on the Form 990 record.

This is me
Organizations
2
Roles reported
2
Reported compensation
$953K

Who this is

Profile

The filed facts are verified from the IRS filings. The biography is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
●
Reported as Chief Scientific Officer & Res. Dir. of Van Andel Research Institute, based in Grand Rapids, MI.
●
Received $953K in total reported compensation on the most recent Form 990 (Part VII).
●
Also listed as Vaigs Director, Vari Cso of Van Andel Institute Graduate School, uncompensated.
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

Peter A. Jones is Chief Scientific Officer of Van Andel Research Institute in Grand Rapids, Michigan, and served as President from 2024 to 2026.

A pioneering cancer epigenetics researcher, he previously directed the USC Norris Comprehensive Cancer Center (1993–2011) and is a fellow of the National Academy of Medicine.

Compiled from public web sources (4 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
Chief Scientific Officer, 2014–2026; President, 2024–2026

Affiliations

Organizations

Linked as the same person by IRS Schedule R, a shared officer mailing address, or shared fellow board members.

Van Andel Research Institute Chief Scientific Officer & Res. Dir. · $112.7M revenue · Grand Rapids, MIMEDICAL RESEARCH ORGANIZATIONpay $753K → $953KFiled FY2023, FY2022, FY2021, FY2020, FY2019 · Source: Form 990, Part VII
$953Kreported comp
Van Andel Institute Graduate School Vaigs Director, Vari Cso · $1.4M revenue · Grand Rapids, MITO DEVELOP BIOMEDICAL RESEARCH LEADERS THROUGH A GRADUATE PROGRAM IN MOLECULAR AND CELL BIOLOGY.Filed FY2023, FY2022, FY2021 · Source: Form 990, Part VII

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

K
Chief Investment Officer · FY2023
$1.1M
T
Assoc Direct-Sr. Portfolio Mgr. · FY2023
$782K
D
Chairman / CEO · FY2023
$692K
D
Chief Operat. Officer (end 4/1/2024) · FY2023
$636K
D
Associate Research Director · FY2021
$536K
A
Senior Portfolio Manager · FY2023
$530K
T
General Counsel · FY2023
$518K
D
Distinguished Investigator · FY2023
$514K
G
Chief Strat. Officer (end 7/5/2024) · FY2023
$508K
T
Vice President & CAO/CFO · FY2023
$493K
D
Sr. Scientific Investigator · FY2022
$439K
D
Sr. Scientific Investigator & Dept. Chair · FY2023
$434K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

Dana-Farber Cancer Institute INC$3.5B revenue · Boston, MA
American Association for Cancer Research INC$129.5M revenue · Philadelphia, PA
The Institute for Cancer Research$94.5M revenue · Philadelphia, PA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

C
Former CEO · Sanford Burnham Prebys Medical Discovery Institute
$5.0M
L
Trustee, President, and CEO · Dana-Farber Cancer Institute
$3.7M
D
VP & Chief Investment Officer · Howard Hughes Medical Institute
$3.6M
D
CEO (thru 12/31/2022) · Transcelerate Biopharma INC
$2.6M
K
President · Sanford Burnham Prebys Medical Discovery Institute
$2.6M
L
President & CEO · Jackson Laboratory
$2.5M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org